Pentixapharm Holding AG annual free cash flow
2022
2023
2024
2025
Pentixapharm Holding AG Free Cash Flow (FCF) History (PTP)
Pentixapharm Holding AG reported −€18.6M in free cash flow for fiscal 2025, a decrease of €14.3M from the previous fiscal year, with a free cash flow margin of −20664.44%.
View full Pentixapharm Holding AG company overviewPentixapharm Holding AG free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2025 | 2025-12-31 | −€18.6M | −€14.3M | — | −20664.44% |
| 2024 | 2024-12-31 | −€4.3M | −€1.5M | — | −3607.50% |
| 2023 | 2023-12-31 | −€2.8M | €3.4M | — | — |
| 2022 | 2022-12-31 | −€6.2M | — | — | — |
Pentixapharm Holding AG quarterly free cash flow
Q1.25
Q2.25
Q3.25
Q4.25
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2025 | 2025-12-31 | −€2.3M | — | — | — |
| Q3 2025 | 2025-09-30 | −€7.2M | — | — | −9155.70% |
| Q2 2025 | 2025-06-30 | −€3.2M | — | — | −16721.05% |
| Q1 2025 | 2025-03-31 | −€5.8M | — | — | −30747.37% |
Pentixapharm Holding AG free cash flow growth trends
Pentixapharm Holding AG's latest reported quarter, Q4 2025, generated −€2.3M in free cash flow.
About the metric
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
Calculation and source
How free cash flow is calculated
TickerStat calculates free cash flow as reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Pentixapharm Holding AG source filings ↗